AXICABTAGENE CILOLEUCEL
UNII U2I8T43Y7R

Substance Identification & Data

This profile provides standardized clinical and technical data for Axicabtagene Ciloleucel, uniquely identified by the FDA Unique Ingredient Identifier (UNII) U2I8T43Y7R.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) 1987398. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

U2I8T43Y7R

CAS Registry Number

N/A

RxNorm Concept ID

1987398

Detailed Substance Profile

Preferred Name

AXICABTAGENE CILOLEUCEL

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

U2I8T43Y7R

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C120309

National Cancer Institute reference terminology for clinical and research data.

INN ID

10518

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

DE-33

Identifier assigned by the United States Adopted Names Council.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

ITIS TSN

180092

Taxonomic Serial Number for species identified in the Integrated Taxonomic Information System.

NCBI Taxonomy

9606

Unique numeric identifier used to specify biological species in the NCBI database.

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Axicabtagene Ciloleucel. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

AXICABTAGENE CILOLEUCEL

Common Names & Synonyms

AUTOLOGOUS T CELLS TRANSDUCED WITH RETROVIRAL VECTOR ENCODING AN ANTI-CD-19 CD28/CD3-ZETA CHIMERIC ANTIGEN RECEPTOR

AXICABTAGENE CILOLEUCEL (AUTOLOGOUS CD19 CAR TRANSDUCED PBL)

AXICABTAGENE CILOLEUCEL [INN]

AXICABTAGENE CILOLEUCEL [USAN]

AXICABTAGENE CILOLEUCEL [WHO-DD]

CELLS ARE DERIVED FROM ISOLATED BLOOD OF THE PATIENT AND ARE TRANSDUCED WITH NON-REPLICATIVE RETROVIRAL VECTOR ENCODING THE FMC63 ANTI-CD19 SINGLE CHAIN VARIABLE FRAGMENT (SCFV) CD28/CD3ZETA CHIMERIC ANTIGEN RECEPTOR (FMC63-28Z CAR). CELLS EXHIBIT ANTI-TUMORAL ACTIVITY IN PATIENTS WITH CD19-EXPRESSING B CELL MALIGNANCIES